These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Imatinib: a review of its use in the management of gastrointestinal stromal tumours. Siddiqui MA; Scott LJ Drugs; 2007; 67(5):805-20. PubMed ID: 17385949 [TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome. Mandalà M; Pezzica E; Tamborini E; Guerra U; Lagonigro SM; Forloni B; Barni S Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):711-3. PubMed ID: 17625442 [TBL] [Abstract][Full Text] [Related]
26. [Indications for pre- and postoperative treatment with imatinib for gastrointestinal stromal tumors]. Heger U; Weitz J; Lordick F Chirurg; 2008 Jul; 79(7):630-7. PubMed ID: 18548219 [TBL] [Abstract][Full Text] [Related]
27. The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. Rutkowski P; Bylina E; Klimczak A; Switaj T; Falkowski S; Kroc J; Lugowska I; Brzeskwiniewicz M; Melerowicz W; Osuch C; Mierzejewska E; Wasielewski K; Woźniak A; Grzesiakowska U; Nowecki ZI; Siedlecki JA; Limon J BMC Cancer; 2012 Mar; 12():107. PubMed ID: 22439647 [TBL] [Abstract][Full Text] [Related]
28. Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor. Fu Y; Hao H; Guo L; Yang G; Zhang X Oncotarget; 2017 Feb; 8(6):10136-10144. PubMed ID: 28052037 [TBL] [Abstract][Full Text] [Related]
35. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424 [TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal stromal tumor: 15-years' experience in a single center. Wang M; Xu J; Zhang Y; Tu L; Qiu WQ; Wang CJ; Shen YY; Liu Q; Cao H BMC Surg; 2014 Nov; 14():93. PubMed ID: 25403624 [TBL] [Abstract][Full Text] [Related]
37. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome. Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146 [TBL] [Abstract][Full Text] [Related]
38. The role of imatinib plasma level testing in gastrointestinal stromal tumor. George S; Trent JC Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S45-50. PubMed ID: 21140148 [TBL] [Abstract][Full Text] [Related]
39. Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132. Wang D; Zhang Q; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M; Eisenberg BL Ann Surg Oncol; 2012 Apr; 19(4):1074-80. PubMed ID: 22203182 [TBL] [Abstract][Full Text] [Related]
40. Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours. Dretzke J; Round J; Connock M; Tubeuf S; Pennant M; Fry-Smith A; Hulme C; McCabe C; Meads C Health Technol Assess; 2010 Oct; 14(Suppl. 2):63-70. PubMed ID: 21047493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]